Publications
Showing 371 to 380 of 555 Publications
| Title | Authors | Year | Journal |
|---|---|---|---|
| Differential Cognitive Decline in Alzheimer’s Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure | Sapkota, S., McFall, G. P.*, Masellis, M.*, Dixon, R. A.*, & Black, S. E.* | 2022 | Journal of Alzheimer's disease |
| Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum | Benedet AL, Milà-Alomà M, Vrillon A, Ashton NJ, Pascoal TA, Lussier FZ, Karikari TK, Hourregue C, Cognat E, Dumurgier J, Stevenson J, Rahmouni N, Pallen V, Poltronetti NM, Salvadó G, Shekari M, Operto G, Gispert JD, Minguillon C, Fauria K, Kollmorgen G, Suridjan I, Zimmer ER, Zetterberg H, Molinuevo JL, Paquet C, Rosa-Neto P*, Blennow K, Suárez-Calvet M, for the Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer’s and Families (ALFA) study, and BioCogBank Paris Lariboisière cohort | 2021 | JAMA Neurology |
| Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative | Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suárez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Moscoso Rial A, Pascoal TA, Andreasson U, Scholl M, Weiner H, Rosa-Neto P*, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H, for the Alzheimer's Disease Neuroimaging Initiative | 2020 | Molecular Psychiatry |
| Developing the Driving Cessation in Dementia Toolkit (DCDT): A Knowledge-to-Action Process | Naglie G*, Stasiulis E, Sanfors S, Bédard M*, Belchior P*, Byzewski A*, Crizzle A*, Gélinas I*, Marshall S*, Mazer B*, Molnar F*, Moorhouse P*, Myers A, Polgar J, Porter M*, Tuokko H, Vrkljan B*, Yamin S*, Rappoport M* on behalt of the CCNA Driving Cessation Team | 2020 | CGS Book of Abstracts |
| Developing the Driving and Dementia Roadmap: a knowledge-to-action process | Stasiulis, E., Naglie, G.*, Sanford, S., Belchior, P.*, Crizzle, A.*, Gélinas, I.*, Mazer, B., Moorhouse, P.*, Myers, A., Porter, M. M.*, Vrkljan, B.*, Rapoport, M. J.*, & Canadian Consortium on Neurodegeneration in Aging Driving and Dementia Team | 2023 | International Psychogeriatrics |
| Developing the Canadian Indigenous Cognitive Assessment for use with Indigenous older Anishinaabe adults in Ontario, Canada | Jacklin K, Pitawanakwat K*, Blind M, O’Connell ME*, Walker J*, Lemieux AM, Warry W | 2021 | Innovation in Aging |
| Determining composition of micron-scale protein deposits in neurodegenerative disease by spatially targeted optical microproteomics | Hadley, K. C., Rakhit, R., Guo, H., Sun, Y., Jonkman, J. E., McLaurin, J., Hazrati, L. N., Emili, A., & Chakrabartty, A. | 2015 | E-Life |
| Determinants of a decline in a nutrition risk measure differ by baseline high nutrition risk status: targeting nutrition risk screening for frailty prevention in the Canadian Longitudinal Study on Aging (CLSA) | Keller, H. H.*, & Trinca, V. | 2023 | Canadian journal of public health = Revue canadienne de sante publique |
| Detection of vision and /or hearing loss using the interRAI Community Health Assessment aligns well with common behavioral vision/hearing measurements | Urqueta Alfaro, A.*, Guthrie, DM.**, Phillips, NA.**, Pichora-Fuller, MK.**, Mick, P.**, McGraw, C.*, Wittich, W**. | 2019 | PLoS One |
| Detection of Active Caspase-3 in Mouse Models of Stroke and Alzheimer’s Disease with a Novel Dual Positron Emission Tomography/Fluorescent Tracer | Ostapchenko, VG., Snir, J., Suchy, M., Fan, J., Cobb, MR., Chronik, BA., Kovacs, M., Prado, VF.**, Hudson, RHE., Pasternak, SH.**, Prado, MAM.**, Bartha, R.** | 2019 | Contrast Media Mol Imaging. |
Showing 371 to 380 of 555 Publications